Ozempic often used off-label) Tirzepatide (Zepbound / Mounjaro) a dual GLP-1/GIP agonist that tends to produce even greater weight loss Liraglutide (Saxenda) Originally developed for Type 2 diabetes, these medications received Health Canada approval for chronic weight management in adults with a BMI 30, or BMI 27 with at least one weight-related condition (such as hypertension, dyslipidemia, or obstructive sleep apnea)
Avoid stacking MOTS-C with multiple peptides that all hit similar receptors
Promotional Pricing and Discounts Some providers offer promotional pricing for first-time users: first month discounted to $149 to $179 to reduce barriers to starting treatment, or bundled pricing if you pay for multiple months upfront (for example, 3 months for $540 instead of $597)
Crajoinas, R
Managing GLP-1 Side Effects: Our Top Tips for Success GLP-1 agonists, like semaglutide and tirzepatide, are groundbreaking treatments for managing type 2 diabetes and obesity
While some patients and clinics report benefits like more energy or less nausea, no large clinical trials have been conducted to confirm these claims